Willow Biosciences Inc
(FRA:3D7)
€
0.0725
0 (0%)
Market Cap: 10.37 Mil
Enterprise Value: 10.64 Mil
PE Ratio: 0
PB Ratio: 10.00
GF Score: 33/100 Willow Biosciences Inc Investor Presentation Transcript
Nov 10, 2022 / 07:00PM GMT
Release Date Price:
€0.065
Operator
Presentation
Nov 10, 2022 / 07:00PM GMT
=====================
Corporate Participants
=====================
* Glen Akselrod
Bristol Capital Ltd. - IR
* Peter Seufer-Wasserthal
Willow Biosciences Inc. - President, CEO
* Troy Talkkari
Willow Biosciences Inc. - VP, Corporate Development
=====================
Glen Akselrod
Bristol Capital Ltd. - IR
Greetings, ladies and gentlemen, and welcome to the Willow Biosciences investor presentation. (Operator Instructions) As a reminder, today's conference is being recorded. And it is now my pleasure to introduce your host, Mr. Glen Akselrod with Bristol Capital. Thank you. Please go ahead.
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot